Skip to main content

ADHD Prevalence Was Steady in U.S. Youth From 2017 to 2022

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Oct. 6, 2023 -- The prevalence of attention-deficit/hyperactivity disorder (ADHD) in U.S. youth remained steady from 2017 to 2022, according to a research letter published online Oct. 4 in JAMA Network Open.

Yanmei Li, from Guangdong Pharmaceutical University in Guangzhou, China, and colleagues estimated the prevalence and trends of ADHD among children and adolescents (aged 4 to 17 years) in the United States from 2017 to 2022 using data from the National Health Interview Survey (37,609 individuals).

The researchers found that 10.9 percent reported to have ever been diagnosed with ADHD, with no significant annual change noted in prevalence (10.0 percent in 2017 and 10.8 percent in 2022). Prevalence did significantly vary by sociodemographic factors. In 2021 to 2022, ADHD prevalence was significantly higher in girls versus boys, those aged 12 to 17 years versus 4 to 11 years, White individuals versus Hispanic or Black individuals, and those living in poverty versus higher income.

"Given that the estimated ADHD prevalence was still high, further investigation is warranted to assess potentially modifiable risk factors and provide adequate resources for treatment of individuals with ADHD in the future," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Mortality in Rheumatic Heart Disease Is High

FRIDAY, June 7, 2024 -- Mortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June...

Higher County-Level Prostate Cancer Screening Tied to Better Outcomes

FRIDAY, June 7, 2024 -- Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and...

Metabolic Impact on Offspring Similar for Frozen, Fresh Embryo Transfer

FRIDAY, June 7, 2024 -- For glucose and lipid profiles during early childhood, the impact of frozen embryo transfer (FET) is comparable to that of fresh embryo transfer, according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.